Bilioenteric Anastomosis by Magnetic Compressive Technique

Pancreatic Cancer Clinical Trial

— BAMCT  

Official title:

Bilioenteric Anastomosis by Magnetic Compressive Technique: A Prospective, Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03774589
• Other study ID #: XJTU1AF-CRF-2015-001-1
• Status: Recruiting
• Phase: N/A
• Start date: February 1, 2019
• Est. completion date: January 31, 2022

Study information

• Verified date: November 2019
• Source: First Affiliated Hospital Xi'an Jiaotong University
• Contact: Yi Lv, MD,PHD
• Phone: 86-29-85323900
• Email: luyi169[@]126.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the magnetic compressive anastomosis has a better outcomes than traditional manual anastomosis on bilioenteric anastomosis.

Description:

The bilioenteric anastomosis is one of the most common and difficult operations in Hepatobiliary Surgery. The traditional manual anastomosis has become one of the main prognosis factors because of the length of suture time, the difficulty of operation, the high incidence of anastomotic leakage and stricture. Magnetic compressive anastomosis can realize the fast anastomosis, reduce the difficulty, and reduce the incidence of anastomotic leakage and stricture. Currently, the majority of studies of magnetic compressive bilioenteric anastomosis are merely confined within clinical case report and single-center, small sample, retrospective study. This study is a prospective, randomized controlled trial. To evaluate the security, reliability and convince of magnetic compressive bilioenteric anastomosis versus traditional suture method on incidence of anastomotic leakage and stricture between magnetic compressive anastomosis and traditional manual anastomosis among patients who need bilioenteric anastomosis operation. The study is to enroll about 200 patients and divide into Study Group (Group A: Magnetic compressive anastomosis) and Control Group (Group B: traditional manual anastomosis) as 1:1 ratio randomly by stratification factors. The incidence of anastomotic leakage and stricture, length of bilioenteric anastomosis time, value of serum bilirubin, length of discharge time of magnetic device and mean time of hospital stay will be evaluated. The patients will drop out of the study if adverse events happen, active request for dropping out, new-onset severe disease or death. The primary and secondary end point will be observed by regular follow-up.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: January 31, 2022
• Est. primary completion date: January 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients with age between 18 to 75

• Patients' gender was not limited

• Patients who were well-diagnosed and had the indication for bilioenteric anastomosis.

• Patients whose lifetimes will be longer than 12 months.

• Patients who are willing to join this clinical trial and informed consent form voluntarily.

Exclusion Criteria:

• Woman during pregnancy or lactation or anyone with mental disorder

• The wall of hepatic duct or jejunum was too thick so that the attractive force of magnetic device cannot meet the requirements of compression.

• Any anatomical variation in bile ducts system or the inner diameter is too small so that the magnetic device cannot place in.

• Any foreign body has been implanted in body, such as heart pacemaker.

• Surgical contraindication, including:

Child-Pugh C with hepatic encephalopathy Anyone with heart, lung, kidney dysfunction or other organ dysfunction, and cannot tolerate surgery.Hepatic ducts stone disease, who was diagnosed as Acute Cholangitis of Severe Type, especially complicated with bacteremia or septic shock. End stage disease, complicated with biliary cirrhosis or portal hypertension.Patients with long- term obstructive jaundice, dehydration, electrolyte disturbance or coagulation defects; Patients have the tendency or history of bleeding.

• Any other disease in perioperation periods which needs MRI examination in the next 8 weeks post operation.

Related Conditions & MeSH terms

• Bile Duct Injury
• Biliary Calculi
• Calculi
• Cholangiocarcinoma
• Choledochal Cyst
• Gallstones
• Pancreatic Cancer

Intervention

Procedure:
• Magnetic Compressive Anastomosis
The magnetic compressive anastomosis will be used to complete the anastomosis during bilioenteric anastomosis.
• Manual Anastomosis
A handsewn technique will be used to complete the anastomosis during bilioenteric anastomosis.

Locations

Country	Name	City	State
China	The First Affiliated Hospital of Xi'an Jiaotong University	Xi'an	Shaanxi

Sponsors (3)

Lead Sponsor	Collaborator
First Affiliated Hospital Xi'an Jiaotong University	Health Science Center of Xi’an Jiaotong University, Northwest Institute for Non-ferrous Metal Research

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Bilioenteric anastomotic leakage	To compare the incidence of biliary leakage after magnetic or hand-sewn anastomosis	1 month post operation
Secondary	Length of bilioenteric anastomosis time	To compare the anastomotic time between magnetic and hand-sewn groups	during operation
Secondary	Time from the date of operation to expel of the magnets.	To confirm the safe discharge of the magnets	1 to 4 weeks postoperation
Secondary	average length of postoperative hospital stay	To compare the length of stay between magnetic and hand-sewn groups	3 months
Secondary	Bilioenteric anastomotic stricture	To compare the long-term outcome between magnetic and hand-sewn groups	1,3,6,12-month post operation